• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-018
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Erosion (1750)
Event Type  Injury  
Manufacturer Narrative
Udi: unknown since the batch/lot number is unknown.An event of erosion was reported.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
The information was obtained from the following literature article: scognamiglio g.Et al, "a very late life-threatening complication after percutaneous closure of an atrial septal defect." can j cardiol.2017 feb;33(2):293.E1-293.E2.At 5 years of age, the male patient underwent a successful implantation of an 18 mm amplatzer septal occluder (aso).Follow-up was uneventful, with serial transthoracic echocardiograms performed on a regular 2-year basis showing correct device position in the absence of residual shunting or any elements suggestive of procedure-related complications.However, 13 years later, at the scheduled assessment, the patient was fully asymptomatic, but the transthoracic echocardiogram showed an aneurysmal dilation of the ascending aorta with an intimal flap in its lumen.At (b)(6), the patient underwent a successful surgical repair with the removal of the aso, asd patch closure, and replacement of the ascending aorta with a polyester graft.Intraoperative findings confirmed erosion of the right atrial roof extending to the adjacent aortic wall at the level of the noncoronary sinus caused by a partial protrusion of the aso atrial disc.At the 1-year assessment, the patient was in good health.Patient identifier and weight is protected under local privacy laws, and therefore is not recorded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key7148829
MDR Text Key95855135
Report Number2135147-2017-00192
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-ASD-018
Device Catalogue Number9-ASD-018
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/27/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age20 YR
-
-